Current partner codePEPTIDESDE
NCT06194019·Not applicable·OBSERVATIONAL

Evaluation of Volume Status Changes in Children on Regular Hemodialysis at Assiut University Children,s Hospital

Status

Unknown

Phase

Not applicable

Enrollment

50

Locations

0

Results

Not posted

Publications

0

Study summary

What the protocol is testing.

Chronic kidney disease (CKD) is a major health problem worldwide.(1) Chronic renal failure is defined as a decrease in glomerular filtration rate (GFR) of less than 60 ml/min/1.73 m2 of body surface evolving for more than 3 months

Full detailed description

Chronic kidney disease (CKD) is a major health problem worldwide.(1) Chronic renal failure is defined as a decrease in glomerular filtration rate (GFR) of less than 60 ml/min/1.73 m2 of body surface evolving for more than 3 months . The etiologies of CKD in children are three main groups of pathologies: congenital anomalies of the kidney and urinary tract , hereditary nephropathies and acquired causes . (2) complication of pediatric hemodialysis is chronic fluid overload, left ventricular hypertrophy ,hypertension, heart failure, decrease arterial flexibility and often results in increase chance of morbidity and mortality, So fluid overload must be prevented .(3) Lung ultrasonography is the most recent, safe, easy, and reliable technique . The most commonly observed finding is a comet tail fanning out from the lung-wall interface and spreading upwards to the edge of the screen, named a "B-line" Chest sonar advantages include its noninvasiveness , ease of use, availability of portable machines, avoidance of radiation detect lung edema even in initial non symptomatic cases known as hidden lung congestion .(4) Bioimpedance analysis (BIA) Bio impedance spectroscopy (BIS) is a technique used to estimate total body water, extracellular water, lean and adipose tissue mass and over hydration . (5) N-terminal pro-brain natriuretic peptide is used as a biomarker to aid to predict cardiac dysfunction in children and adolescents .(6)it is an effective marker of volume status in patient with or without reduced ejection fraction undergoing hemodialysis. (7)

Interventions

Treatment arms and agents.

DEVICE

lung ultrasonography

N-terminal pro-brain natriuretic peptide (NT-proBNP) as a biomarker for detection volume overload.

Timeline

From registration to results.

  1. First posted

    Jan 8, 2024

  2. Study start

    Jul 1, 2024

  3. Primary completion

    Jul 1, 2026

  4. Study completion

    Jul 1, 2026

  5. Results posted

    Not reported

  6. Registry updated

    Jan 17, 2024

Outcomes

What the study measures.

Primary outcomes

Evaluation of volume status changes in children on regular hemodialysis at Assiut university children's hospital

Time frame · two year

Evaluation of Volume status in children on regular haemodialysis by Chest sonar Evaluation of Volume status in children on regular haemodialysis by Chest sonar Evaluation of Volume status in children on regular haemodialysis by Chest sonar Evaluation of Volume status in children on regular haemodialysis by Chest sonar Evaluation of Volume status in children on regular haemodialysis by Chest sonar

Secondary outcomes

Not reported in the indexed record.

Eligibility

Who can take part.

Minimum age
3 Years
Maximum age
18 Years
Sex
ALL
Healthy volunteers
Not reported

Inclusion Criteria: \- Patients aged 3 to 16 years having end stage renal disease undergoing regular haemodialysis for at least more than 6 months of both gender were enrolled Exclusion Criteria: * Patients with chronic lung disease ,or pulmonary infection in the last 2 months were excluded from study. Patients with congestive heart failure Patients with Pulmonary edema Patient with pericardial effusion parental refusal to participate

Study locations

0 registered sites.

No country data reported. Showing up to 24 locations stored in the fast local snapshot.

No study locations reported.

Publications

Results and literature.

No PMID-linked publications were present in this registry snapshot.

Primary links

Continue at the source.

Related trials

More studies on Nesiritide.

Related PeptideStat pages

Put the record in context.

Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.